Treatment of the Patients with Growth Hormone-Secreting Adenomas in the Regional Medical Center: Comparison with National Register
Journal of Neurological Surgery Part B: Skull Base · 01.02.2024 · 85 (S 01 S 01) · S1-S398
DOI: 10.1055/s-0044-1780048 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Neurological Surgery Part B: Skull Base, erschienen am 01.02.2024. Verfasst von Bakhtiyar Pashaev und 5 weiteren Autor:innen.
Abstract (Originalsprache)
Background
Transnasal surgery remains a treatment of choice in patients with growth hormone(GH) secreting pituitary adenomas(PA). But postoperative disease control rate varies from center to center.
Objective
To assay results of the surgical treatment among patients with GH-secretin PA operated in the regional medical center. And compare results with the data of the National Register (Russian Register-RR). Materials and Methods: Adult population of Republic of Tatarstan accounts 3.5 million people. A total 284 patients with acromegaly included in Regional Register. From 2007 to 2023, a total 257 patients with GH-secretin PA underwent surgery and medication at a single institution. Twelve patients were operated outside our region. A retrospective review of patient’s medical records was performed. Obtained data were compared with data of the Russian National Register and World Register of the patients with acromegaly.
Results
A total of 257 (94.5%) patients underwent surgery as a primary treatment and 15 (5.5%) patents received somatostatin analogs of first generation (SSA1) initially. There were 94 (36.6%) males and 163 (63.4%) females. Patient age was between 19 and 76 years (mean: 46.8 years). According to the size, 69 patients had micro adenoma, 179 had macro adenoma, and 9 had giant adenoma. With regard to the Knosp classification, grade 0 had 145 patients, grade 1 had 52 patients, grade 2 had 28 patients, grade 3 had 18, and grade 4 had 14 patients. A 62.5% of the patients had Ki-67 3%. All patients were operated via transnasal approach: 37 (14.4%) with microscope and other 220 (85.6%) purely endoscopic. In 10 (3.9%) patients, a selective resection of the medial wall of the cavernous sinus in addition to the standard endoscopic endonasal approach was performed. Assessment of disease control was performed on days 7 to 10 after surgery by determining serum IGF-1, basal GH, and in OGTT. Then 3 and 6 months postoperatively, a complete remission of the acromegaly after surgery was observed in 116 (45.1%) patients. 76 (29.8%) patients developed a biochemical control of disease after surgery added by a low dose of the SSA1 medication. In 60 (23.4%) patients, remission of the acromegaly was not achieved. Comparing obtained results with our national register (RR) we found that in Republic of Tatarstan, surgery was used as a first-line treatment in 94% of cases, while in RR (49.6%), complete postoperative disease control in our series was 45.1%, RR—40.5%. Absence of remission in our series was 23.4% while in RR it was 43.2%.
Conclusions
Surgery alone as a first line of treatment gives a 45.1% control of the acromegaly, with a prevalence in patients with microadenomas (55%) and les control in those with macro- (43%) and giant (33%) adenomas. Combination of the surgery with the low-dose SSA1 gives a disease control up to 75%. Publication History Article published online: 05 February 2024 © 2024. Thieme. All rights reserved. Georg Thieme Verlag KG Rüdigerstraße 14, 70469 Stuttgart, Germany
Zitieren
APA
Pashaev, B., Vagapova, G., Pichugin, A., Alekseev, A., Khafizov, A., & Ashimova, R. (2024). Treatment of the Patients with Growth Hormone-Secreting Adenomas in the Regional Medical Center: Comparison with National Register. Journal of Neurological Surgery Part B: Skull Base, 85(S 01 S 01), S1-S398. https://doi.org/10.1055/s-0044-1780048
Vancouver
Pashaev B, Vagapova G, Pichugin A, Alekseev A, Khafizov A, Ashimova R. Treatment of the Patients with Growth Hormone-Secreting Adenomas in the Regional Medical Center: Comparison with National Register. Journal of Neurological Surgery Part B: Skull Base. 2024;85(S 01 S 01):S1-S398. doi:10.1055/s-0044-1780048
BibTeX
@article{Pashaev2024,
author = {Pashaev, Bakhtiyar and Vagapova, Gulnar and Pichugin, Arseniy and Alekseev, Andrey and Khafizov, Artur and Ashimova, Regina},
title = {Treatment of the Patients with Growth Hormone-Secreting Adenomas in the Regional Medical Center: Comparison with National Register},
journal = {Journal of Neurological Surgery Part B: Skull Base},
year = {2024},
volume = {85},
number = {S 01 S 01},
pages = {S1--S398},
doi = {10.1055/s-0044-1780048}
}
EUVIMED